Method of treatment of estrogen deficiency disease

Details Method of treatment of estrogen deficiency disease Method of treatment of estrogen deficiency disease

1984-03-28

1986-08-12

Roberts, Albert L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

A61K 3156

Patent

active

046056491

ABSTRACT:
2,4-Difluoro-.beta.-estradiol, 2-fluoro-.beta.-estradiol, and related fluoro estrogens used to treat estrogen-deficiency states in human females with genetic predisposition to cancer of estrogen-sensitive tissues.

REFERENCES:
patent: 4340602 (1982-07-01), Brooks
patent: 4496555 (1985-01-01), Brooks
Hertz, "Cancer", 38 (1976) p. 534.
Goodman and Gilman's, "The Pharmacological Basis of Therapeutics (Chapter 6), pp. 1426-1431.

Affiliated with

Also associated with

Rating

Method of treatment of estrogen deficiency disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment of estrogen deficiency disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of estrogen deficiency disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1935573